GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

According to Taylor Fazio, RD, a wellness advisor at The Lanby in New York City, fiber supplements can support digestive ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so,” ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.